Search results
Bristol-Myers Squibb Company (NYSE:BMY) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 12 hours agoBristol-Myers Squibb Company (NYSE:BMY) Q1 2024 Earnings Call Transcript April 25, 2024...
Judge tosses Medicare drug negotiation challenges from Bristol Myers Squibb, Johnson & Johnson
The Hill· 10 hours agoA federal judge on Monday threw out legal challenges to the Medicare negotiation program that had...
A Closer Look at Bristol-Myers Squibb's Options Market Dynamics - Bristol-Myers Squibb (NYSE:BMY)
Benzinga· 12 hours agoLoading... Loading... Financial giants have made a conspicuous bearish move on Bristol-Myers Squibb. Our analysis of options history for Bristol-Myers Squibb BMY revealed 9 unusual trades. Delving ...
Why Bristol Myers Squibb Stock Is Sinking Today
Motley Fool via Yahoo Finance· 5 days agoShares of Bristol Myers Squibb (NYSE: BMY) were down 8.3% as of 11:19 a.m. ET on Thursday. The sell-off came after the big drugmaker announced its...
Bristol-Myers Squibb Layoffs 2024: What to Know About the Latest BMY Job Cuts
InvestorPlace· 5 days agoBristol-Myers Squibb (NYSE:BMY) layoffs are a hot topic on Thursday after the biopharmaceutical...
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 14 hours agoBristol Myers Squibb (BMY) is one of the stocks most watched by Zacks.com visitors lately. So, it...
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug-price negotiations
CNBC· 1 day agoA federal judge in New Jersey on Monday rejected Johnson & Johnson's and Bristol Myers Squibb's...
Bristol-Myers Squibb Expected to Earn Q2 2024 Earnings of $1.76 Per Share (NYSE:BMY)
ETF DAILY NEWS· 2 days agoBristol-Myers Squibb (NYSE:BMY – Free Report) – Equities research analysts at Leerink Partnrs lowered their Q2 2024 EPS estimates for shares of Bristol-Myers Squibb in a report issued on Thursday ...
Bristol-Myers Squibb stock target cut on cost cutting measures By Investing.com
Investing.com· 1 day agoOn Monday, Deutsche Bank (ETR:DBKGn) adjusted its outlook on Bristol-Myers Squibb Co. shares...
Scenic Biotech Enters into Research Collaboration with Bristol Myers Squibb - Bristol-Myers Squibb...
Benzinga· 18 hours agoScenic Biotech, a pioneer in the field of modifier therapies for severe genetic disorders, today announced that it has entered into a research collaboration with Bristol Myers Squibb BMY to ...